Original Research

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression

Zou X, Fan W, Xue M, Li J

Cancer Management and Research 2021, 13:4013-4029

Published Date: 18 May 2021